Occupy CFS RFA ticker at zero

Who Me?

Well-Known Member
The RFA Ticker continues to show a big fat ZERO for ME/CFS research, but there is one interesting bit of research-related bit news. NIH has issued an updated notice about the Lipkin samples. These samples were collected as part of the Lipkin study of XMRV, and were collected from very well characterized ME/CFS patients. The notice states that NIH considers these samples to be “an extremely valuable resource,” and:

http://www.occupycfs.com/2016/02/22/rfa-ticker-22216/
 

Cort

Founder of Health Rising and Phoenix Rising
Staff member
The RFA Ticker continues to show a big fat ZERO for ME/CFS research, but there is one interesting bit of research-related bit news. NIH has issued an updated notice about the Lipkin samples. These samples were collected as part of the Lipkin study of XMRV, and were collected from very well characterized ME/CFS patients. The notice states that NIH considers these samples to be “an extremely valuable resource,” and:

http://www.occupycfs.com/2016/02/22/rfa-ticker-22216/
Simmaron is using those samples in its vector borne illness study but I wonder if anyone else has even applied. I wouldn't be surprised if they haven't.
 

weyland

Well-Known Member
Why don't they give them to Dr. Nath so he can get a head start on some of the serology for their study.
 

Forum Tips

Support Our Work

DO IT MONTHLY

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Shopping on Amazon.com For HR

Latest Resources

Top